KARYOPHARM THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.06 USD | 0.00% |
|
-9.40% | +22.54% |
Chart calendar Karyopharm Therapeutics Inc.
d7aff00a8b32.6_qXEkmcDc7x88sbe-XXZL8QGOsv3850yYquxMzZFJA.nKrHdxbDQKK7yvp2QteNVeUiYNpdjak7nrrLs4OdIumgneBVesN7uaKBng~4d37c26d4b5b968a64682a28e0a84fad
Upcoming events on Karyopharm Therapeutics Inc.
Past events on Karyopharm Therapeutics Inc.
| 2024-03-13 09:00 am | Barclays Global Healthcare Conference - Fireside Chat |
| 2024-03-11 | Leerink Partners Global Biopharma Conference |
| 2024-02-29 08:00 am | Q4 2023 Earnings Call |
| 2024-02-29 07:30 am | Q4 2023 Earnings Release |
| 2024-01-10 05:15 pm | JPMorgan Healthcare Conference |
| 2023-11-29 04:00 pm | Piper Sandler Healthcare Conference |
| 2023-11-15 08:00 am | Jefferies London Healthcare Conference |
| 2023-11-06 07:15 am | International Gynecological Cancer Society Global Meeting - The evolving landscape in molecular-driv |
| 2023-11-05 04:30 pm | International Gynecological Cancer Society Global Meeting - Selinexor maintenance for patients with |
| 2023-11-04 | International Gynecological Cancer Society Global Meeting - ENGOT-EN20/GOG-3083/XPORT-EC-042 A phase |
| 2023-11-02 08:00 am | Q3 2023 Earnings Call |
| 2023-11-02 07:30 am | Q3 2023 Earnings Release |
| 2023-10-01 05:05 am | European Society of Gynaecological Oncology Congress - Abstract # 264 |
| 2023-09-30 11:05 am | European Society of Gynaecological Oncology Congress - Abstract # 265 |
| 2023-09-29 06:15 am | International Myeloma Society Meeting - Abstract # P-396 |
| 2023-09-28 05:30 am | International Myeloma Society Meeting - Abstract # P-297 |
| 2023-09-28 05:30 am | International Myeloma Society Meeting - Abstract # P-295 |
| 2023-09-28 05:30 am | International Myeloma Society Meeting - Abstract # P-241 |
| 2023-09-28 05:30 am | International Myeloma Society Meeting - Abstract # P-232 |
| 2023-09-28 05:30 am | International Myeloma Society Meeting - Abstract # P-323 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 40,9 39,1 4.61% | 108 103 5.38% | 210 133 57.59% | 157 157 -0.16% | 146 146 0.09% | 147 |
|
EBITDA Million USD | Released Forecast Spread | -188 -191 1.41% | -171 -179 4.69% | -97,5 -199 50.92% | -142 -137 -3.59% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -189 -185 -2.15% | -172 -174 1.34% | -98,3 -173 43.31% | -142 -138 -2.69% | -130 -125 -3.93% | -129 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -200 -194 -2.93% | -196 -198 1.2% | -124 -201 38.53% | -165 -159 -3.66% | -143 -135 -5.64% | -148 |
|
Net income Million USD | Released Forecast Spread | -200 -193 -3.18% | -196 -197 0.13% | -124 -191 34.94% | -165 -159 -3.76% | -143 -134 -6.48% | -146 |
|
EPS USD | Released Forecast Spread | -3,22 -3,14 -2.49% | -2,72 -2,75 1.04% | -1,65 -2,53 34.74% | -2,02 -1,92 -4.98% | -1,25 -1,18 -6.16% | -1,23 |
| Announcement Date | 13/02/20 | 11/02/21 | 08/02/22 | 15/02/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 126 52,7 139.53% | 47,7 34,4 38.54% | 39,7 36,0 10.33% | 36,1 34,8 3.76% | 33,6 33,7 -0.49% | 38,7 36,3 6.59% | 37,6 35,7 5.36% | 36,0 37,4 -3.73% | 33,7 33,6 0.39% | 34,5 | 36,4 | 37,5 | 38,1 | 44,5 |
|
EBITDA Million USD | Released Forecast Spread | 47,1 -51,0 192.35% | -34,4 -49,0 29.78% | -36,6 -46,0 20.45% | -30,7 -35,0 12.41% | -33,8 -26,0 -29.83% | -30,6 -41,0 25.34% | -29,5 -34,0 13.26% | -31,2 -34,0 8.29% | ||||||
|
EBIT Million USD | Released Forecast Spread | 47,0 -23,9 296.71% | -34,6 -43,2 19.92% | -42,9 -40,4 -6.18% | -30,8 -35,9 14.17% | -33,9 -29,8 -13.49% | -30,9 -33,4 7.6% | -29,6 -35,0 15.46% | -31,3 -28,0 -11.68% | -37,8 -32,9 -14.87% | -33,5 | -31,9 | -31,3 | -32,3 | -22,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 38,6 -38,9 199.23% | -41,3 -51,8 20.29% | -48,9 -49,3 0.74% | -36,3 -44,4 18.24% | -38,4 -32,7 -17.51% | -34,1 -39,9 14.67% | -32,5 -39,5 17.79% | -34,5 -31,2 -10.72% | -41,7 -34,1 -22.17% | -39,3 | -37,3 | -35,3 | -36,3 | |
|
Net income Million USD | Released Forecast Spread | 38,7 -28,0 238.38% | -41,4 -50,8 18.47% | -49,1 -48,4 -1.35% | -36,3 -44,3 18.09% | -38,5 -32,7 -17.92% | -34,1 -39,6 13.92% | -32,6 -39,5 17.42% | -34,5 -31,0 -11.47% | -41,8 -33,2 -26% | -39,9 | -37,3 | -34,5 | -34,0 | |
|
EPS USD | Released Forecast Spread | 0,46 -0,36 226.52% | -0,53 -0,67 20.53% | -0,62 -0,61 -1.25% | -0,45 -0,55 18.78% | -0,43 -0,34 -24.65% | -0,30 -0,38 20% | -0,29 -0,35 16.33% | -0,30 -0,25 -18.9% | -0,36 -0,29 -23.08% | -0,35 | -0,32 | -0,30 | -0,26 | |
| Announcement Date | 08/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 15/02/23 | 04/05/23 | 02/08/23 | 02/11/23 | 29/02/24 | - | - | - | - | - |
More events
Past sector events for Karyopharm Therapeutics Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KPTI Stock
- Calendar Karyopharm Therapeutics Inc.
